Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
Date:5/2/2013

tions; whether or when Arena submits for marketing approval in the EU; regulatory decisions in one territory may impact regulatory decisions in other territories and Arena's business prospects; risks related to commercializing drugs, including regulatory, manufacturing and supply issues and the pace of market acceptance; cash and revenues generated from BELVIQ, including the impact of competition; Arena's revenues will be based in part on management's estimates, judgment and accounting policies, and incorrect estimates or disagreement regarding Arena's estimates or accounting policies may result in changes to Arena's guidance or previously reported results; the timing and outcome of regulatory review is uncertain, and BELVIQ may not be approved for marketing when expected or ever by any other regulatory agency; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative arrangements; the timing and receipt of payments and fees, if any, from collaborators; the entry into or modification or termination of collaborative arrangements; unexpected or unfavorable new data; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies m
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
11. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing ... It has been publicly recognized that ... a series of challenges in the recent years. ... overcapacities in small molecule product manufacturing; increasingly challenging ...
(Date:7/7/2015)... 2015  PAREXEL International Corporation (NASDAQ: PRXL ) will ... 2015 on Wednesday, August 5 th , 2015 after the ... on PAREXEL,s website at www.PAREXEL.com and on the ... host a conference call and live webcast at 10:00 a.m. ... the results.  To access the webcast, visit PAREXEL,s website at ...
(Date:7/7/2015)...   Bionik Laboratories Corp. (OTCBB: BNKL), ... core focus in robotic exoskeleton technology for users ... today that it has completed an additional sale ... its common stock and warrants for aggregate gross ... placement transaction.  This equity financing is the sixth ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... August 10, 2011 Agendia, a commercial-stage ... St. Gallen International Breast Cancer Conference (2011) Expert Panel,s ... patients by the particular biological subtype of their tumor ... According to the panel, "it is no longer tenable ...
... August 10, 2011 The report " ... Current Trends & Forecasts (2010   -   2015) ... administration, and applications; and studies the major market drivers, restraints, ... in North America (U.S. and Canada), Europe, Asia, Japan, ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015 2MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015 3
(Date:7/7/2015)... ... ... Safe Catch is setting revolutionary purity limits for canned tuna as the only ... Markets, Sprouts Farmers Market and Wegmans are some of the first grocers to stock ... mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch tuna for health ...
(Date:7/7/2015)... ... 07, 2015 , ... The Immune Deficiency Foundation (IDF) launched ... using its IDF ePHR, an electronic personal health record powered by Get Real ... track their health information, including symptoms, diagnoses, medications, infusions and other critical health ...
(Date:7/7/2015)... Manistee, Michigan (PRWEB) , ... July 07, 2015 , ... ... a fundraising golf outing at the Manistee Golf and Country Club. Best Drug Rehabilitation ... went to a good cause, helping underprivileged children. Kiwanis International, the parent of the ...
(Date:7/7/2015)... ... July 07, 2015 , ... On June ... the site of the National Baptist Convention 110th Annual Session of the National ... promoting the collaboration of churches and their congregations, medical professionals and health-related organizations, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for ... communities throughout Georgia, announces the launch of the first ambulance telemedicine program in ... County, GA. The new program will not only provide more immediate patient care, ...
Breaking Medicine News(10 mins):Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... say in a new study that parents are unaware of ... survey of 591 children aged 12 to 17, the researchers ... habits. ,Even among those children who had clear ... the study said. Details can be found in the journal ...
... allergic to them. Now they can rejoice for a new ... on sale for a whooping ?2,500!, // ,A ... off allergic reactions to cats. These special cats were bred ... on thousands of cats before identifying the perfect breed. , ...
... 24-half marathons in 24 consecutive days will not only raise ... to his employer. ,Young ran the 18th of ... step towards the noble cause. ,"I am very ... my endeavour to raise 100,000 pounds for Cancer Research UK," ...
... of the prostate could be life threatening. September has been ... skin cancer// prostrate cancer has been found to be the ... country with one out of every three men diagnosed with ... ,Prostate health is especially important for African-American men with death ...
... skilled obstetricians has left more women with the option ... of labor//, often in situations where a natural birth ... ,Obstetric trainees are often likely to opt ... obstetricians due to inexperience. ,Some of the common ...
... of polio in India on "unscientific" policy and "inadequacy" of ... ,Polio cases have risen to 297 so far this ... Indian strains of the virus in neighbouring Nepal and Bangladesh ... Organization (WHO). ,Thekakkara Jacob John, an authority on ...
Cached Medicine News:Health News:Cancer Survivor Runs Half-marathon 2Health News:C-Section A More Common Choice Nowadays 2Health News:Polio Outbreak in India due to Vaccine Failure, Says Expert 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: